View in EDS HTML Full Text PDF Full Text

Tildrakizumab 200 mg: a step forward in psoriasis treatment with added metabolic benefits.

Saved in:
Bibliographic Details
Title: Tildrakizumab 200 mg: a step forward in psoriasis treatment with added metabolic benefits.
Authors: Lanna, Caterina1 (AUTHOR) caterinalanna.cl@gmail.com, Rivieccio, Antonia1 (AUTHOR), Cattani, Chiara1 (AUTHOR), Artosi, Fabio1 (AUTHOR), Bianchi, Luca1 (AUTHOR), Campione, Elena1 (AUTHOR)
Source: Journal of Dermatological Treatment. Dec2025, Vol. 36 Issue 1, p1-7. 7p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:09546634
DOI:10.1080/09546634.2025.2512159